08 of Sept., 2022 – participation in the FACT-bridge 2022 Antithrombotic Therapy Forum.

D.G. Tovbin, D.N. Tarasov, A.N. Kovalenko made oral presentations from our company.
The main activities of the "PharmaDiall" company are search, development, chemical synthesis, "in vitro" and "in vivo" testing, organization and performing the clinical trials (all phases) and patenting of new biologically active chemicals that can later turn into drugs.